Johnson and Johnson announces financial results

Johnson and Johnson has released the details of its financial results of the third quarter of the year.

The firm revealed that its sales reached $15.1 billion (9.43 billion pounds) during the period, while its operational results declined by 2.8 per cent compared to the same period of 2008.

Net earnings and diluted earnings per share for the third quarter were $3.3 billion and $1.20 respectively, representing increases of 1.1 per cent and 2.6 per cent, compared to the same timeframe last year.

William Weldon, chairman and chief executive of the organisation, said: “We completed multiple acquisitions and strategic collaborations and received several new product approvals in the quarter that will benefit patients worldwide and drive future growth.”

News of Johnson and Johnson’s finances comes after one of its companies, Ethicon Endo-Surgery, received the Gold 2009 International Design Excellence Award for the research and design of its curved shear, entitled the Harmonic Focus.